Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 180

1.

Author's reply to: Implementation and organization of cancer screening in France.

Basu P, Ponti A, Anttila A, Ronco G, Senore C, Vale DB, Segnan N, Tomatis M, Soerjomataram I, Primic Žakelj M, Dillner J, Elfström KM, Lönnberg S, Sankaranaryanan R.

Int J Cancer. 2018 Jun 26. doi: 10.1002/ijc.31629. [Epub ahead of print] No abstract available.

PMID:
29943811
2.

Breast and cervical cancer incidence and mortality trends in Russia 1980-2013.

Barchuk A, Bespalov A, Huhtala H, Chimed T, Laricheva I, Belyaev A, Bray F, Anttila A, Auvinen A.

Cancer Epidemiol. 2018 Aug;55:73-80. doi: 10.1016/j.canep.2018.05.008. Epub 2018 May 26.

PMID:
29843073
3.

An in vitro evaluation of browser and grazer fermentation efficiency and microbiota using European moose spring and summer foods.

Krizsan SJ, Mateos-Rivera A, Bertilsson S, Felton A, Anttila A, Ramin M, Vaga M, Gidlund H, Huhtanen P.

Ecol Evol. 2018 Mar 31;8(8):4183-4196. doi: 10.1002/ece3.3920. eCollection 2018 Apr.

4.

Invitation strategies and coverage in the population-based cancer screening programmes in the European Union.

Vale DB, Anttila A, Ponti A, Senore C, Sankaranaryanan R, Ronco G, Segnan N, Tomatis M, Žakelj MP, Elfström KM, Lönnberg S, Dillner J, Basu P.

Eur J Cancer Prev. 2018 Mar 21. doi: 10.1097/CEJ.0000000000000426. [Epub ahead of print]

PMID:
29570103
5.

Author's reply to: Cancer screening policy in Hungary.

Basu P, Ponti A, Anttila A, Ronco G, Senore C, Vale DB, Segnan N, Tomatis M, Soerjomataram I, Primic Žakelj M, Dillner J, Elfström KM, Lönnberg S, Sankaranarayanan R.

Int J Cancer. 2018 Aug 15;143(4):1005. doi: 10.1002/ijc.31371. Epub 2018 Mar 30. No abstract available.

PMID:
29524204
6.

The National Healthcare Safety Network Long-term Care Facility Component early reporting experience: January 2013-December 2015.

Palms DL, Mungai E, Eure T, Anttila A, Thompson ND, Dudeck MA, Edwards JR, Bell JM, Stone ND.

Am J Infect Control. 2018 Jun;46(6):637-642. doi: 10.1016/j.ajic.2018.01.003. Epub 2018 Feb 22.

7.

Health care-associated infections studies project: An American Journal of Infection Control and National Healthcare Safety Network data quality collaboration.

Allen-Bridson K, Gross C, Anttila A, Brooks JE, Hebden JN, Leaptrot D, Ryan G, Scalise E, Smith H, Wright MO.

Am J Infect Control. 2017 Dec 1;45(12):1394-1395. doi: 10.1016/j.ajic.2017.09.011.

PMID:
29195584
8.

Impact of organized and opportunistic Pap testing on the risk of cervical cancer in young women - A case-control study from Finland.

Makkonen P, Heinävaara S, Sarkeala T, Anttila A.

Gynecol Oncol. 2017 Dec;147(3):601-606. doi: 10.1016/j.ygyno.2017.09.010. Epub 2017 Sep 21.

9.

Status of implementation and organization of cancer screening in The European Union Member States-Summary results from the second European screening report.

Basu P, Ponti A, Anttila A, Ronco G, Senore C, Vale DB, Segnan N, Tomatis M, Soerjomataram I, Primic Žakelj M, Dillner J, Elfström KM, Lönnberg S, Sankaranarayanan R.

Int J Cancer. 2018 Jan 1;142(1):44-56. doi: 10.1002/ijc.31043. Epub 2017 Oct 10. Erratum in: Int J Cancer. 2018 Jul 1;143(1):E1.

PMID:
28940326
10.

Interpretation Modalities Used on Family-Centered Rounds: Perspectives of Spanish-Speaking Families.

Anttila A, Rappaport DI, Tijerino J, Zaman N, Sharif I.

Hosp Pediatr. 2017 Aug;7(8):492-498. doi: 10.1542/hpeds.2016-0209. Epub 2017 Jul 13.

11.

A cohort mortality study of lead-exposed workers in the USA, Finland and the UK.

Steenland K, Barry V, Anttila A, Sallmén M, McElvenny D, Todd AC, Straif K.

Occup Environ Med. 2017 Nov;74(11):785-791. doi: 10.1136/oemed-2017-104311. Epub 2017 May 25.

PMID:
28546320
12.

Health care-associated infections studies project: An American Journal of Infection Control and National Healthcare Safety Network data quality collaboration.

Smith H, Brooks JE, Leaptrot D, Allen-Bridson K, Anttila A, Gross C, Hebden JN, Ryan G, Scalise E, Wright MO.

Am J Infect Control. 2017 Jun 1;45(6):612-614. doi: 10.1016/j.ajic.2017.01.031. Epub 2017 Apr 18.

13.

High lifetime probability of screen-detected cervical abnormalities.

Pankakoski M, Heinävaara S, Sarkeala T, Anttila A.

J Med Screen. 2017 Dec;24(4):201-207. doi: 10.1177/0969141316685740. Epub 2017 Jan 10.

14.

Cumulative risk of false positive test in relation to breast symptoms in mammography screening: a historical prospective cohort study.

Singh D, Pitkäniemi J, Malila N, Anttila A.

Breast Cancer Res Treat. 2016 Sep;159(2):305-13. doi: 10.1007/s10549-016-3931-8. Epub 2016 Aug 5.

15.

Health care-associated infections studies project: An American Journal of Infection Control and National Healthcare Safety Network data quality collaboration 2016 Case #1.

Hebden JN, Leaptrot D, Anttila A, Allen-Bridson K, Brooks JE, Gross C, Scalise E, Wright MO.

Am J Infect Control. 2016 Jul 1;44(7):761-3. doi: 10.1016/j.ajic.2016.02.031. Epub 2016 May 9. No abstract available.

16.

Impact of organised mammography screening on breast cancer mortality in a case-control and cohort study.

Heinävaara S, Sarkeala T, Anttila A.

Br J Cancer. 2016 Apr 26;114(9):1038-44. doi: 10.1038/bjc.2016.68. Epub 2016 Mar 24.

17.

Self-sampling in cervical cancer screening: comparison of a brush-based and a lavage-based cervicovaginal self-sampling device.

Karjalainen L, Anttila A, Nieminen P, Luostarinen T, Virtanen A.

BMC Cancer. 2016 Mar 15;16:221. doi: 10.1186/s12885-016-2246-9.

18.

Performance indicators in a newly established organized cervical screening programme: registry-based analysis in the Czech Republic.

Májek O, Dušková J, Dvořák V, Beková A, Klimeš D, Blaha M, Anttila A, Dušek L.

Eur J Cancer Prev. 2017 May;26(3):232-239. doi: 10.1097/CEJ.0000000000000236.

PMID:
26908155
19.

European Code against Cancer, 4th Edition: Cancer screening.

Armaroli P, Villain P, Suonio E, Almonte M, Anttila A, Atkin WS, Dean PB, de Koning HJ, Dillner L, Herrero R, Kuipers EJ, Lansdorp-Vogelaar I, Minozzi S, Paci E, Regula J, Törnberg S, Segnan N.

Cancer Epidemiol. 2015 Dec;39 Suppl 1:S139-52. doi: 10.1016/j.canep.2015.10.021.

20.

European Code against Cancer 4th Edition: Infections and Cancer.

Villain P, Gonzalez P, Almonte M, Franceschi S, Dillner J, Anttila A, Park JY, De Vuyst H, Herrero R.

Cancer Epidemiol. 2015 Dec;39 Suppl 1:S120-38. doi: 10.1016/j.canep.2015.10.006. Epub 2015 Nov 14.

21.

The costs of offering HPV-testing on self-taken samples to non-attendees of cervical screening in Finland.

Virtanen A, Anttila A, Nieminen P.

BMC Womens Health. 2015 Nov 5;15:99. doi: 10.1186/s12905-015-0261-7.

22.

Effectiveness of screening for colorectal cancer with a faecal occult-blood test, in Finland.

Pitkäniemi J, Seppä K, Hakama M, Malminiemi O, Palva T, Vuoristo MS, Järvinen H, Paimela H, Pikkarainen P, Anttila A, Elovainio L, Hakulinen T, Karjalainen S, Pylkkänen L, Rautalahti M, Sarkeala T, Vertio H, Malila N.

BMJ Open Gastroenterol. 2015 Jun 8;2(1):e000034. doi: 10.1136/bmjgast-2015-000034. eCollection 2015.

23.

Health Care-Associated Infections Studies Project Case #1: A 2015 American Journal of Infection Control and National Healthcare Safety Network data quality collaboration.

Gross C, Allen-Bridson K, Anttila A, Brooks JE, Hebden JN, Leaptrot D, Morabit S, Wright MO.

Am J Infect Control. 2015 Sep 1;43(9):987-8. doi: 10.1016/j.ajic.2015.05.029. Epub 2015 Jul 21. No abstract available.

24.

Health Care-Associated Infections Studies Project Case #2: a 2015 American Journal of Infection Control and National Healthcare Safety Network data quality collaboration.

Allen-Bridson K, Anttila A, Brooks JE, Gross C, Hebden JN, Leaptrot D, Morabit S, Wright MO.

Am J Infect Control. 2015 Oct 1;43(10):1099-101. doi: 10.1016/j.ajic.2015.05.028. Epub 2015 Jul 21. No abstract available.

25.

The implementation of an organised cervical screening programme in Poland: an analysis of the adherence to European guidelines.

Nowakowski A, Cybulski M, Śliwczyński A, Chil A, Teter Z, Seroczyński P, Arbyn M, Anttila A.

BMC Cancer. 2015 Apr 14;15:279. doi: 10.1186/s12885-015-1242-9.

26.

Mammography screening in three Finnish residential areas: comprehensive population-based study of breast cancer incidence and incidence-based mortality 1976-2009.

Parvinen I, Heinävaara S, Anttila A, Helenius H, Klemi P, Pylkkänen L.

Br J Cancer. 2015 Mar 3;112(5):918-24. doi: 10.1038/bjc.2014.642. Epub 2015 Feb 17.

27.

Kidney cancer risk in oil refining in Finland: a nested case-referent study.

Anttila A, Pokhrel A, Heikkilä P, Viinanen R, Pukkala E.

J Occup Environ Med. 2015 Jan;57(1):68-72. doi: 10.1097/JOM.0000000000000301.

PMID:
25563542
28.

Towards better implementation of cancer screening in Europe through improved monitoring and evaluation and greater engagement of cancer registries.

Anttila A, Lönnberg S, Ponti A, Suonio E, Villain P, Coebergh JW, von Karsa L.

Eur J Cancer. 2015 Jan;51(2):241-51. doi: 10.1016/j.ejca.2014.10.022. Epub 2014 Dec 4.

29.

Self-sampling experiences among non-attendees to cervical screening.

Virtanen A, Nieminen P, Niironen M, Luostarinen T, Anttila A.

Gynecol Oncol. 2014 Dec;135(3):487-94. doi: 10.1016/j.ygyno.2014.09.019. Epub 2014 Oct 2.

PMID:
25284037
30.

Improving cervical cancer screening attendance in Finland.

Virtanen A, Anttila A, Luostarinen T, Malila N, Nieminen P.

Int J Cancer. 2015 Mar 15;136(6):E677-84. doi: 10.1002/ijc.29176. Epub 2014 Sep 15.

31.

Association of symptoms and breast cancer in population-based mammography screening in Finland.

Singh D, Malila N, Pokhrel A, Anttila A.

Int J Cancer. 2015 Mar 15;136(6):E630-7. doi: 10.1002/ijc.29170. Epub 2014 Sep 4.

32.

International variation in management of screen-detected ductal carcinoma in situ of the breast.

Ponti A, Lynge E, James T, Májek O, von Euler-Chelpin M, Anttila A, Fitzpatrick P, Mano MP, Kawai M, Scharpantgen A, Fracheboud J, Hofvind S, Vidal C, Ascunce N, Salas D, Bulliard JL, Segnan N, Kerlikowske K, Taplin S; ICSN DCIS Working group.

Eur J Cancer. 2014 Oct;50(15):2695-704. doi: 10.1016/j.ejca.2014.07.019. Epub 2014 Aug 19.

33.

Pregnancy incidence and outcome before and after cervical intraepithelial neoplasia: a retrospective cohort study.

Kalliala I, Anttila A, Nieminen P, Halttunen M, Dyba T.

Cancer Med. 2014 Dec;3(6):1512-6. doi: 10.1002/cam4.300. Epub 2014 Aug 21.

34.

Overdiagnosis due to breast cancer screening: updated estimates of the Helsinki service study in Finland.

Heinävaara S, Sarkeala T, Anttila A.

Br J Cancer. 2014 Sep 23;111(7):1463-8. doi: 10.1038/bjc.2014.413. Epub 2014 Aug 14.

35.

Lack of significant effects of Chlamydia trachomatis infection on cervical cancer risk in a nested case-control study in North-East Thailand.

Tungsrithong N, Kasinpila C, Maneenin C, Namujju PB, Lehtinen M, Anttila A, Promthet S.

Asian Pac J Cancer Prev. 2014;15(3):1497-500.

36.

Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis.

Arbyn M, Verdoodt F, Snijders PJ, Verhoef VM, Suonio E, Dillner L, Minozzi S, Bellisario C, Banzi R, Zhao FH, Hillemanns P, Anttila A.

Lancet Oncol. 2014 Feb;15(2):172-83. doi: 10.1016/S1470-2045(13)70570-9. Epub 2014 Jan 14. Review.

PMID:
24433684
37.

Breast carcinoma detection modes and death in a female population in relation to population-based mammography screening.

Sarkeala T, Luostarinen T, Dyba T, Anttila A.

Springerplus. 2014 Jul 8;3:348. doi: 10.1186/2193-1801-3-348. eCollection 2014.

38.

Divergent coverage, frequency and costs of organised and opportunistic Pap testing in Finland.

Salo H, Nieminen P, Kilpi T, Auranen K, Leino T, Vänskä S, Tiihonen P, Lehtinen M, Anttila A.

Int J Cancer. 2014 Jul 1;135(1):204-13. doi: 10.1002/ijc.28646. Epub 2013 Dec 18.

39.

Type- and age-specific distribution of human papillomavirus in women attending cervical cancer screening in Finland.

Leinonen MK, Anttila A, Malila N, Dillner J, Forslund O, Nieminen P.

Br J Cancer. 2013 Nov 26;109(11):2941-50. doi: 10.1038/bjc.2013.647. Epub 2013 Oct 17.

40.

[Self-sampling and reminder letters increase participation in the Finnish cervical cancer screening programme].

Virtanen A, Nieminen P, Malila N, Luostarinen T, Anttila A.

Duodecim. 2013;129(16):1709-17. Finnish.

PMID:
24069641
41.

Variation in detection of ductal carcinoma in situ during screening mammography: a survey within the International Cancer Screening Network.

Lynge E, Ponti A, James T, Májek O, von Euler-Chelpin M, Anttila A, Fitzpatrick P, Frigerio A, Kawai M, Scharpantgen A, Broeders M, Hofvind S, Vidal C, Ederra M, Salas D, Bulliard JL, Tomatis M, Kerlikowske K, Taplin S; ICSN DCIS Working group.

Eur J Cancer. 2014 Jan;50(1):185-92. doi: 10.1016/j.ejca.2013.08.013. Epub 2013 Sep 13.

42.

Healthcare-associated infections studies project: an American Journal of Infection Control and National Healthcare Safety Network data quality collaboration-LabID Clostridium Difficile event 2013.

Hebden JN, Anttila A, Allen-Bridson K, Morrell GC, Wright MO, Horan T.

Am J Infect Control. 2013 Oct;41(10):916-7. doi: 10.1016/j.ajic.2013.05.009. Epub 2013 Aug 5.

PMID:
23928030
43.

The responses of Vitreoscilla hemoglobin-expressing hybrid aspen (Populus tremula × tremuloides) exposed to 24-h herbivory: expression of hemoglobin and stress-related genes in exposed and nonorthostichous leaves.

Sutela S, Ylioja T, Jokipii-Lukkari S, Anttila AK, Julkunen-Tiitto R, Niemi K, Mölläri T, Kallio PT, Häggman H.

J Plant Res. 2013 Nov;126(6):795-809. doi: 10.1007/s10265-013-0569-z. Epub 2013 Jun 7.

PMID:
23744275
44.

Risk of cancer among workers exposed to trichloroethylene: analysis of three Nordic cohort studies.

Hansen J, Sallmén M, Seldén AI, Anttila A, Pukkala E, Andersson K, Bryngelsson IL, Raaschou-Nielsen O, Olsen JH, McLaughlin JK.

J Natl Cancer Inst. 2013 Jun 19;105(12):869-77. doi: 10.1093/jnci/djt107. Epub 2013 May 30.

PMID:
23723420
45.

National Healthcare Safety Network report, data summary for 2011, device-associated module.

Dudeck MA, Horan TC, Peterson KD, Allen-Bridson K, Morrell G, Anttila A, Pollock DA, Edwards JR.

Am J Infect Control. 2013 Apr;41(4):286-300. doi: 10.1016/j.ajic.2013.01.002. No abstract available.

46.

European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication.

European Colorectal Cancer Screening Guidelines Working Group, von Karsa L, Patnick J, Segnan N, Atkin W, Halloran S, Lansdorp-Vogelaar I, Malila N, Minozzi S, Moss S, Quirke P, Steele RJ, Vieth M, Aabakken L, Altenhofen L, Ancelle-Park R, Antoljak N, Anttila A, Armaroli P, Arrossi S, Austoker J, Banzi R, Bellisario C, Blom J, Brenner H, Bretthauer M, Camargo Cancela M, Costamagna G, Cuzick J, Dai M, Daniel J, Dekker E, Delicata N, Ducarroz S, Erfkamp H, Espinàs JA, Faivre J, Faulds Wood L, Flugelman A, Frkovic-Grazio S, Geller B, Giordano L, Grazzini G, Green J, Hamashima C, Herrmann C, Hewitson P, Hoff G, Holten I, Jover R, Kaminski MF, Kuipers EJ, Kurtinaitis J, Lambert R, Launoy G, Lee W, Leicester R, Leja M, Lieberman D, Lignini T, Lucas E, Lynge E, Mádai S, Marinho J, Maučec Zakotnik J, Minoli G, Monk C, Morais A, Muwonge R, Nadel M, Neamtiu L, Peris Tuser M, Pignone M, Pox C, Primic-Zakelj M, Psaila J, Rabeneck L, Ransohoff D, Rasmussen M, Regula J, Ren J, Rennert G, Rey J, Riddell RH, Risio M, Rodrigues V, Saito H, Sauvaget C, Scharpantgen A, Schmiegel W, Senore C, Siddiqi M, Sighoko D, Smith R, Smith S, Suchanek S, Suonio E, Tong W, Törnberg S, Van Cutsem E, Vignatelli L, Villain P, Voti L, Watanabe H, Watson J, Winawer S, Young G, Zaksas V, Zappa M, Valori R.

Endoscopy. 2013;45(1):51-9. doi: 10.1055/s-0032-1325997. Epub 2012 Dec 4.

47.

Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.

Arbyn M, Ronco G, Anttila A, Meijer CJ, Poljak M, Ogilvie G, Koliopoulos G, Naucler P, Sankaranarayanan R, Peto J.

Vaccine. 2012 Nov 20;30 Suppl 5:F88-99. doi: 10.1016/j.vaccine.2012.06.095. Review. Erratum in: Vaccine. 2013 Dec 16;31(52):6266.

PMID:
23199969
48.

Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland.

Leinonen MK, Nieminen P, Lönnberg S, Malila N, Hakama M, Pokhrel A, Laurila P, Tarkkanen J, Anttila A.

BMJ. 2012 Nov 29;345:e7789. doi: 10.1136/bmj.e7789.

49.

Mammographic screening programmes in Europe: organization, coverage and participation.

Giordano L, von Karsa L, Tomatis M, Majek O, de Wolf C, Lancucki L, Hofvind S, Nyström L, Segnan N, Ponti A; Eunice Working Group, Van Hal G, Martens P, Májek O, Danes J, von Euler-Chelpin M, Aasmaa A, Anttila A, Becker N, Péntek Z, Budai A, Mádai S, Fitzpatrick P, Mooney T, Zappa M, Ventura L, Scharpantgen A, Hofvind S, Seroczynski P, Morais A, Rodrigues V, Bento MJ, Gomes de Carvalho J, Natal C, Prieto M, Sánchez-Contador Escudero C, Zubizarreta Alberti R, Fernández Llanes SB, Ascunce N, Ederra Sanza M, Sarriugarte Irigoien G, Salas Trejo D, Ibáñez Cabanell J, Wiege M, Ohlsson G, Törnberg S, Korzeniewska M, de Wolf C, Fracheboud J, Patnick J J, Lancucki L, Ducarroz S, Suonio E.

J Med Screen. 2012;19 Suppl 1:72-82.

PMID:
22972813
50.

False-positive results in mammographic screening for breast cancer in Europe: a literature review and survey of service screening programmes.

Hofvind S, Ponti A, Patnick J, Ascunce N, Njor S, Broeders M, Giordano L, Frigerio A, Törnberg S; EUNICE Project and Euroscreen Working Groups, Van Hal G, Martens P, Májek O, Danes J, von Euler-Chelpin M, Aasmaa A, Anttila A, Becker N, Péntek Z, Budai A, Mádai S, Fitzpatrick P, Mooney T, Zappa M, Ventura L, Scharpantgen A, Hofvind S, Seroczynski P, Morais A, Rodrigues V, Bento MJ, Gomes de Carvalho J, Natal C, Prieto M, Sánchez-Contador Escudero C, Zubizarreta Alberti R, Fernández Llanes SB, Ascunce N, Ederra Sanza M, Sarriugarte Irigoien G, Salas Trejo D, Ibáñez Cabanell J, Wiege M, Ohlsson G, Törnberg S, Korzeniewska M, de Wolf C, Fracheboud J, Patnick J, Lancucki L, Ducarroz S, Suonio E.

J Med Screen. 2012;19 Suppl 1:57-66. Review.

PMID:
22972811

Supplemental Content

Loading ...
Support Center